Finasteride (FIN), another FDA-approved AGA treatment, inhibits HF atrophy by reversing the process of AGA by inhibiting the 5α-reductase type 2 (SRD5A2) gene in scalp HF [169]. The gene discussed is SRD5A2; the disease is hydrops fetalis.